Life-Saving Devices Reach the End of Life with Heart Failure

Progress in Cardiovascular Diseases

Volumn 55, Issue 3, 2012, Pages 274-281

  Matlock, Daniel D ^a,b   Stevenson, Lynne Warner ^c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CRT; Deactivation; DT; Heart failure; HF; ICD; Implantable cardioverter defibrillators; Left ventricular assist devices; Palliative care; VAD

Indexed keywords

ANTICIPATION; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EXAMINATION; CUSTODY; DEVICE DEACTIVATION; DEVICE REMOVAL; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICOLEGAL ASPECT; MORTALITY; PALLIATIVE THERAPY; PATIENT DECISION MAKING; PATIENT PREFERENCE; PREOPERATIVE PERIOD; QUALITY OF LIFE; RELIGION; RISK BENEFIT ANALYSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; TERMINAL CARE; TREATMENT WITHDRAWAL; VENTRICULAR ASSIST DEVICE;

ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; TERMINAL CARE;

EID: 84870482278     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2012.10.007     Document Type: Article

References (44)

1. Fang J.C. Rise of the machines-left ventricular assist devices as permanent therapy for advanced heart failure. N Engl J Med 2009, 361:2282-2285.
2. Ezekowitz J.A., Rowe B.H., Dryden D.M., et al. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med 2007, 147:251-262. [Review].
3. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352:225-237. [see comment] [erratum appears in N Engl J Med. 2005 May 19;352(20):2146].
4. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877-883.
5. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation 2005, 112:e154-e235.
6. Centers for Medicare and Medicaid Services Decision memo for implantable defibrillators Available from:, Accessed April 24, 2009. http://www.cmshhs.gov/mcd/viewdecisionmemo.asp?id=148.
7. Hammill S.C., Kremers M.S., Stevenson L.W., et al. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm 2010, 7:1340-1345. [Review].
8. Daubert J.C., Saxon L., Adamson P.B., et al. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm 2012, 9:1524-1576.
9. Tang D.G., Oyer P.E., Mallidi H.R. Ventricular assist devices: history, patient selection, and timing of therapy. J Cardiovasc Transl Res 2009, 2:159-167. [Review].
10. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001, 345:1435-1443.
11. Slaughter M.S., Rogers J.G., Milano C.A., et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009, 361:2241-2251.
12. Toda K., Yonemoto Y., Fujita T., et al. Risk analysis of bloodstream infection during long-term left ventricular assist device support. Ann Thorac Surg 2012, 94:1387-1393.
13. Morgan J.A., Paone G., Nemeh H.W., et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2012, 31:715-718.
14. Kirklin J.K., Naftel D.C., Kormos R.L., et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant 2012, 31:117-126.
15. Kovacs A.H., Feigofsky S., Goff J.S., et al. Implantable cardioverter defibrillator implant-explant-implant case study: addressing the psychological adjustment to multiple shocks. Clin Cardiol 2006, 29(6):274-276.
16. Kramer DB., Kesselheim AS., Salberg L., et al. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy. Am J Cardiol 2011, 107:1071-1075.e5.
17. Sherazi S., Zareba W., Daubert J.P., et al. Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators. Cardiol J 2010, 17:267-273.
18. Mueller P.S., Jenkins S.M., Bramstedt K.A., et al. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes. Pacing Clin Electrophysiol 2008, 31:560-568.
19. Kelley A.S., Reid M.C., Miller D.H., et al. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey. Am Heart J 2009, 157:702-708.
20. Morrison L.J., Calvin A.O., Nora H., et al. Managing cardiac devices near the end of life: a survey of hospice and palliative care providers. Am J Hosp Palliat Med 2010, 27:545-551.
21. Goldstein N.E., Mehta D., Teitelbaum E., et al. "It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life. J Gen Intern Med 2008, 23(Suppl. 1):2-6. [see comment].
22. Marinskis G., van Erven L. EHRA Scientific Initiatives Committee. Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey. Europace 2010, 12:1176-1177.
23. Hauptman P.J., Swindle J., Hussain Z., et al. Physician attitudes toward end-stage heart failure: a national survey. Am J Med 2008, 121:127-135.
24. Kapa S., Mueller P.S., Hayes D.L., et al. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients. Mayo Clin Proc 2010, 85:981-990.
25. Goldstein N.E., Mehta D., Siddiqui S., et al. "That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med 2008, 23(Suppl. 1):7-12.
26. Goldstein N.E., Lampert R., Bradley E., et al. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004, 141:835-838. [see comment][summary for patients in Ann Intern Med. 2004 Dec 7;141(11):I38; PMID: 15583220].
27. Goldstein N., Carlson M., Livote E., et al. Brief communication: management of implantable cardioverter-defibrillators in hospice: a nationwide survey. Ann Intern Med 2010, 152:296-299.
28. Lewis W.R., Luebke D.L., Johnson N.J., et al. Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med 2006, 119:892-896.
29. Vitale C.A., Chandekar R., Rodgers P.E., et al. A call for guidance in the use of left ventricular assist devices in older adults. J Am Geriatr Soc 2012, 60:145-150.
30. Samuels L.E., Casanova-Ghosh E., Rodriguez R., et al. Left ventricular assist device implantation in high risk destination therapy patients: an alternative surgical approach. J Cardiothorac Surg 2012, 7:21.
31. MacIver J., Ross H.J. Withdrawal of ventricular assist device support. J Palliat Care 2005, 21:151-156.
32. Mueller P.S., Swetz K.M., Freeman M.R., et al. Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc 2010, 85:791-797.
33. Lachman V.D. Left ventricular assist device deactivation: ethical issues. Medsurg Nurs 2011, 20:98-100.
34. Dudzinski D.M. Ethics guidelines for destination therapy. Ann Thorac Surg 2006, 81:1185-1188.
35. Swetz K.M., Freeman M.R., AbouEzzeddine O.F., et al. Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin Proc 2011, 86:493-500.
36. Matlock D.D., Nowels C.T., Masoudi F.A., et al. Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study. Pacing Clin Electrophysiol 2011, 34:1634-1644.
37. Caverly T.J., Al-Khatib S.M., Kutner J.S., et al. Patient preference in the decision to place implantable cardioverter-defibrillators. Arch Intern Med 2012, 172:1104-1105.
38. Sudore R.L., Schillinger D. Interventions to improve care for patients with limited health literacy. J Clin Outcomes Manage 2009, 16:20-29.
39. Stevenson L.W., Desai A.S. Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure. J Card Fail 2006, 12:407-412. [see comment] [Review].
40. Krumholz H.M. Informed consent to promote patient-centered care. JAMA 2010, 303:1190-1191.
41. Allen L.A., Stevenson L.W., Grady K.L., et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation 2012, 125:1928-1952.
42. Kramer D.B., Buxton A.E., Zimetbaum P.J. Time for a change-a new approach to ICD replacement. N Engl J Med 2012, 366:291-293.
43. Lampert R., Hayes D.L., Annas G.J., et al. HRS expert consensus statement on the management of cardiovascular implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010, 7:1008-1026.
44. King J.S., Moulton B.W. Rethinking informed consent: the case for shared medical decision-making. Am J Law Med 2006, 32(4):429-501.